Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|175|4|693-707

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.175, Iss.4, 2018-02, pp. : 693-707

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A novel selective and orally bioavailable Nav1.8 channel blocker, PF‐01247324, attenuates nociception and sensory neuron excitability

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 10, 2015-05 ,pp. : 2654-2670

John Wiley & Sons Inc

Access to resources Recommend Favorite

Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. 1, 2018-01 ,pp. : 102-112

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pathological features of preclinical or early clinical stages of corticobasal degeneration: a comparison with advanced cases

By  

NEUROPATHOLOGY & APPLIED NEUROBIOLOGY, Vol. 41, Iss. 7, 2015-12 ,pp. : 893-905

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biochemical markers, liver biopsy, or magnetic resonance elastography to detect or exclude advanced fibrosis in patients with nonalcoholic fatty liver disease

By  

HEPATOLOGY, Vol. 62, Iss. 1, 2015-07 ,pp. : 324-325

John Wiley & Sons Inc

Access to resources Recommend Favorite

The pan‐caspase inhibitor Emricasan (IDN‐6556) decreases liver injury and fibrosis in a murine model of non‐alcoholic steatohepatitis

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 953-966

John Wiley & Sons Inc

Access to resources Recommend Favorite